These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 27770071)

  • 1. Seizure variables and their relationship to genotype and functional abilities in the CDKL5 disorder.
    Fehr S; Wong K; Chin R; Williams S; de Klerk N; Forbes D; Krishnaraj R; Christodoulou J; Downs J; Leonard H
    Neurology; 2016 Nov; 87(21):2206-2213. PubMed ID: 27770071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional abilities in children and adults with the CDKL5 disorder.
    Fehr S; Downs J; Ho G; de Klerk N; Forbes D; Christodoulou J; Williams S; Leonard H
    Am J Med Genet A; 2016 Nov; 170(11):2860-2869. PubMed ID: 27528505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the phenotype of the CDKL5 deficiency disorder: Are seizures mandatory?
    MacKay CI; Bick D; Prokop JW; Muñoz I; Rouse J; Downs J; Leonard H
    Am J Med Genet A; 2020 May; 182(5):1217-1222. PubMed ID: 32034940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset.
    MacKay CI; Wong K; Demarest ST; Benke TA; Downs J; Leonard H
    Clin Genet; 2021 Jan; 99(1):157-165. PubMed ID: 33047306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients.
    Archer HL; Evans J; Edwards S; Colley J; Newbury-Ecob R; O'Callaghan F; Huyton M; O'Regan M; Tolmie J; Sampson J; Clarke A; Osborne J
    J Med Genet; 2006 Sep; 43(9):729-34. PubMed ID: 16611748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the ketogenic diet to manage refractory epilepsy in CDKL5 disorder: Experience of >100 patients.
    Lim Z; Wong K; Olson HE; Bergin AM; Downs J; Leonard H
    Epilepsia; 2017 Aug; 58(8):1415-1422. PubMed ID: 28605011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key clinical features to identify girls with CDKL5 mutations.
    Bahi-Buisson N; Nectoux J; Rosas-Vargas H; Milh M; Boddaert N; Girard B; Cances C; Ville D; Afenjar A; Rio M; Héron D; N'guyen Morel MA; Arzimanoglou A; Philippe C; Jonveaux P; Chelly J; Bienvenu T
    Brain; 2008 Oct; 131(Pt 10):2647-61. PubMed ID: 18790821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early-onset epileptic encephalopathy caused by CDKL5 mutation].
    Hjalmgrim H; Hansen LK; Ousager LB; Møller RS
    Ugeskr Laeger; 2014 Dec; 176(25A):. PubMed ID: 25497626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of CDKL5 disorder: improved ADL by simple treatment strategy for intractable epileptic seizures].
    Shike T; Takahashi Y; Kimura N; Imai K; Yamamoto T; Takahashi T
    No To Hattatsu; 2017 Jan; 49(1):28-31. PubMed ID: 30011151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evolution and epilepsy outcome in three patients with CDKL5-related developmental encephalopathy.
    Bernardo P; Ferretti A; Terrone G; Santoro C; Bravaccio C; Striano S; Coppola A; Striano P
    Epileptic Disord; 2019 Jun; 21(3):271-277. PubMed ID: 31225800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aged heterozygous Cdkl5 mutant mice exhibit spontaneous epileptic spasms.
    Mulcahey PJ; Tang S; Takano H; White A; Davila Portillo DR; Kane OM; Marsh ED; Zhou Z; Coulter DA
    Exp Neurol; 2020 Oct; 332():113388. PubMed ID: 32585155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A framework for understanding quality of life domains in individuals with the CDKL5 deficiency disorder.
    Tangarorang J; Leonard H; Epstein A; Downs J
    Am J Med Genet A; 2019 Feb; 179(2):249-256. PubMed ID: 30561084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical manifestations and epilepsy treatment in Japanese patients with pathogenic CDKL5 variants.
    Kobayashi Y; Tohyama J; Takahashi Y; Goto T; Haginoya K; Inoue T; Kubota M; Fujita H; Honda R; Ito M; Kishimoto K; Nakamura K; Sakai Y; Takanashi JI; Tanaka M; Tanda K; Tominaga K; Yoshioka S; Kato M; Nakashima M; Saitsu H; Matsumoto N
    Brain Dev; 2021 Apr; 43(4):505-514. PubMed ID: 33436160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-linked cellular mosaicism underlies age-dependent occurrence of seizure-like events in mouse models of CDKL5 deficiency disorder.
    Terzic B; Cui Y; Edmondson AC; Tang S; Sarmiento N; Zaitseva D; Marsh ED; Coulter DA; Zhou Z
    Neurobiol Dis; 2021 Jan; 148():105176. PubMed ID: 33197557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights in phenomenology and treatment of epilepsy in CDKL5 encephalopathy.
    Melikishvili G; Epitashvili N; Tabatadze N; Chikvinidze G; Dulac O; Bienvenu T; Gataullina S
    Epilepsy Behav; 2019 May; 94():308-311. PubMed ID: 30898514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vagus nerve stimulation for the treatment of refractory epilepsy in the CDKL5 Deficiency Disorder.
    Lim Z; Wong K; Downs J; Bebbington K; Demarest S; Leonard H
    Epilepsy Res; 2018 Oct; 146():36-40. PubMed ID: 30071384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The three stages of epilepsy in patients with CDKL5 mutations.
    Bahi-Buisson N; Kaminska A; Boddaert N; Rio M; Afenjar A; Gérard M; Giuliano F; Motte J; Héron D; Morel MA; Plouin P; Richelme C; des Portes V; Dulac O; Philippe C; Chiron C; Nabbout R; Bienvenu T
    Epilepsia; 2008 Jun; 49(6):1027-37. PubMed ID: 18266744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development.
    Demarest ST; Olson HE; Moss A; Pestana-Knight E; Zhang X; Parikh S; Swanson LC; Riley KD; Bazin GA; Angione K; Niestroj LM; Lal D; Juarez-Colunga E; Benke TA
    Epilepsia; 2019 Aug; 60(8):1733-1742. PubMed ID: 31313283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent mutations in the CDKL5 gene: genotype-phenotype relationships.
    Bahi-Buisson N; Villeneuve N; Caietta E; Jacquette A; Maurey H; Matthijs G; Van Esch H; Delahaye A; Moncla A; Milh M; Zufferey F; Diebold B; Bienvenu T
    Am J Med Genet A; 2012 Jul; 158A(7):1612-9. PubMed ID: 22678952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caregiver Perspective of Benefits and Side Effects of Anti-Seizure Medications in CDKL5 Deficiency Disorder from an International Database.
    Wong K; Junaid M; Alexander S; Olson HE; Pestana-Knight EM; Rajaraman RR; Downs J; Leonard H
    CNS Drugs; 2024 Sep; 38(9):719-732. PubMed ID: 39060900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.